Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.
Year: 1998
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1502100938
